Stock Events

Stock Events

Search...

Protalix BioTherapeutics (PLX) Q3 2024 Earnings

14AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.07

-0.04

-0.01

0.02

Details

Expected EPS

0.02

Actual EPS

-0.03

Surprise EPS

-0.05

Surprise Percent

+250%

Description

Protalix BioTherapeutics (PLX) has reported earnings of -0.03 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.